drugset / Trial / NCT06495931

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

NCT06495931

Phase 1 Completed 24 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This study was designed as a single-center, single-arm, open, fixed-sequence, self-controlled trial in healthy subjects.

Timeline

Start
2024-07-15
Primary completion
2024-08-13
Completion
2024-08-13

Drugs

EvaluationDrugModalityDoseRoute
Subject HR20033 Unknown
Subject HRS-1780 Small molecule
Subject HRS-7535 Small molecule